GSK plans to invest $30 billion on research, development and supply chain infrastructure in the U.S. over the next five years. The plan includes $1.2 billion for new manufacturing facilities and ...

Secures the company's first U.S.-based manufacturing site, strengthening and diversifying its global supply network Additional investments planned to expand the site's capacity (currently at 60,000 ...

The pharmaceutical industry’s pledges to build more U.S. manufacturing capacity are piling up. GSK and Eli Lilly on Tuesday were the latest multinational drugmakers to unveil plans to build new U.S.

GSK plc GSK has unveiled a $30 billion investment plan in research and development (R&D) and supply chain infrastructure in the United States, which will be executed over the next five years. GSK’s ...